We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 15/10/2020 06:17 | Morning all. Interesting day ahead for us shareholders. Any ideas on where today's closing price will be. It's niggling me why one of the big Pharmas haven't stepped in and stumped up what is effectively small change for them to fund the stage 3 trials. | paraguay | |
| 14/10/2020 22:37 | Northern66 you had the right idea taking the 50% profit. I bought in at 220. After sitting back for so long I dived in today. Nervous is a understatement. | yazzieb | |
| 14/10/2020 22:32 | large pharma do takeovers in final phases or post approval. Merck was an exception this year acquiring two small companies on the covid front in preclinical stages. it will come, any hint of success in a phase 3 trial ans sng will be grabbed. expect an acquisition in north of 2.0 bln pounds. | qnq | |
| 14/10/2020 22:32 | large pharma do takeovers in final phases or post approval. Merck was an exception this year acquiring two small companies on the covid front in preclinical stages. it will come, any hint of success in a phase 3 trial ans sng will be grabbed. expect an acquisition in north of 2.0 bln pounds. | qnq | |
| 14/10/2020 22:31 | large pharma do takeovers in final phases or post approval. Merck was an exception this year acquiring two small companies on the covid front in preclinical stages. it will come, any hint of aucceas in a phase 3 trial ans sng will be grabbed. expect an acquisition in north of 2.0 bln pounds. | qnq |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
